271 related articles for article (PubMed ID: 23565677)
1. Recent patents on mesenchymal stem cell mediated therapy in inflammatory diseases.
Nair M; Saxena P
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):105-13. PubMed ID: 23565677
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells as therapeutics.
Parekkadan B; Milwid JM
Annu Rev Biomed Eng; 2010 Aug; 12():87-117. PubMed ID: 20415588
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 May; 8(5):. PubMed ID: 31100966
[TBL] [Abstract][Full Text] [Related]
4. Characterization and therapeutic applications of mesenchymal stem cells for regenerative medicine.
Wang J; Chen Z; Sun M; Xu H; Gao Y; Liu J; Li M
Tissue Cell; 2020 Jun; 64():101330. PubMed ID: 32473704
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
Wang S; Zhu R; Li H; Li J; Han Q; Zhao RC
Front Med; 2019 Apr; 13(2):138-151. PubMed ID: 30062557
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell therapy for acute and chronic pancreatitis.
Kawakubo K; Ohnishi S; Kuwatani M; Sakamoto N
J Gastroenterol; 2018 Jan; 53(1):1-5. PubMed ID: 28646417
[TBL] [Abstract][Full Text] [Related]
7. The Role of Mesenchymal Stem/Stromal Cells Secretome in Macrophage Polarization: Perspectives on Treating Inflammatory Diseases.
Ti D; Yi J; Chen H; Hao H; Shi C
Curr Stem Cell Res Ther; 2024; 19(6):894-905. PubMed ID: 37723965
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.
Cunningham CJ; Redondo-Castro E; Allan SM
J Cereb Blood Flow Metab; 2018 Aug; 38(8):1276-1292. PubMed ID: 29768965
[TBL] [Abstract][Full Text] [Related]
9. Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases.
Ryu JS; Jeong EJ; Kim JY; Park SJ; Ju WS; Kim CH; Kim JS; Choo YK
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171878
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases.
Chen X; Wang S; Cao W
Cell Immunol; 2018 Apr; 326():8-14. PubMed ID: 28778534
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
Wang LT; Ting CH; Yen ML; Liu KJ; Sytwu HK; Wu KK; Yen BL
J Biomed Sci; 2016 Nov; 23(1):76. PubMed ID: 27809910
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
Fan XL; Zhang Z; Ma CY; Fu QL
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?
Bernardo ME; Pagliara D; Locatelli F
Bone Marrow Transplant; 2012 Feb; 47(2):164-71. PubMed ID: 21478914
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells in allergic diseases: Current status.
Li H; Tian Y; Xie L; Liu X; Huang Z; Su W
Allergol Int; 2020 Jan; 69(1):35-45. PubMed ID: 31445840
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270
[TBL] [Abstract][Full Text] [Related]
18. A mesenchymal stem cell potency assay.
Jiao J; Milwid JM; Yarmush ML; Parekkadan B
Methods Mol Biol; 2011; 677():221-31. PubMed ID: 20941614
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?
Marofi F; Vahedi G; Hasanzadeh A; Salarinasab S; Arzhanga P; Khademi B; Farshdousti Hagh M
J Cell Physiol; 2019 Feb; 234(2):1268-1288. PubMed ID: 30191962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
